{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:58:53Z","timestamp":1791374333419,"version":"4.3.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004913","name":"Universit\u00e0 degli Studi di Palermo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020323","name":"Amryt Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jacl.2025.10.073","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:14:54Z","timestamp":1762215294000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access program"],"prefix":"10.1016","volume":"20","author":[{"given":"Antonina","family":"Giammanco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-4667","authenticated-orcid":false,"given":"Laura","family":"D\u2019Erasmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Iannuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Noto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Montali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7096-5201","authenticated-orcid":false,"given":"Alberto","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Suppressa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo M.","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola M.","family":"Gagliardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-0285","authenticated-orcid":false,"given":"Emilio","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-2451","authenticated-orcid":false,"given":"Daniele","family":"Tramontano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Brancatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Arca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo B.","family":"Cefal\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Averna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacl.2025.10.073_bib0001","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.jacl.2025.10.073_bib0002","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronemia-current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat.Rev.Endocrinol"},{"key":"10.1016\/j.jacl.2025.10.073_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100978","article-title":"Recognition and management of persistent chylomicronemia: a joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology","volume":"22","author":"Saadatagah","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacl.2025.10.073_bib0004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.12.019","article-title":"Chylomicronemia: differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","volume":"283","author":"Paquette","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.10.073_bib0005","doi-asserted-by":"crossref","unstructured":"Javed F, Hegele RA, Garg A, et al. Familial chylomicronemia syndrome: an expert clinical review from the National Lipid Association. J Clin Lipidol. 19(3):382-403. doi: 10.1016\/j.jacl.2025.03.013","DOI":"10.1016\/j.jacl.2025.03.013"},{"issue":"11","key":"10.1016\/j.jacl.2025.10.073_bib0006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11883-021-00967-8","article-title":"Rare treatments for rare dyslipidemias: new perspectives in the treatment of homozygous familial hypercholesterolemia (HoFH) and familial chylomicronemia syndrome (FCS)","volume":"23","author":"D\u2019Erasmo","year":"2021","journal-title":"Curr Atherosclerosis Rep"},{"issue":"4","key":"10.1016\/j.jacl.2025.10.073_bib0007","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacl.2018.04.010","article-title":"Familial chylomicronemia syndrome: bringing to life dietary recommendations throughout the life span","volume":"12","author":"Williams","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacl.2025.10.073_bib0008","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.R200014-JLR200","article-title":"Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly","volume":"44","author":"Hussain","year":"2003","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.jacl.2025.10.073_bib0009","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.10.073_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2022.08.017","article-title":"Efficacy and safety of lomitapide in familial chylomicronaemia syndrome","volume":"359","author":"Cefal\u00f9","year":"2022","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.jacl.2025.10.073_bib0011","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4254\/wjh.v7.i8.1149","article-title":"Normal liver stiffness: a study in living donors with normal liver histology","volume":"7","author":"Alsebaey","year":"2015","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.jacl.2025.10.073_bib0012","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jacl.2025.10.073_bib0013","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfetion","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jacl.2025.10.073_bib0014","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/eurjpc\/zwab229","article-title":"Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study","volume":"29","author":"D'Erasmo","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.jacl.2025.10.073_bib0015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/jcm10040669","article-title":"Non-alcoholic fatty liver in patients with chylomicronemia","volume":"10","author":"Maltais","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.jacl.2025.10.073_bib0016","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jamainternmed.2013.13309","article-title":"Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide","volume":"174","author":"Sacks","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.jacl.2025.10.073_bib0017","first-page":"1164","article-title":"Lomitapide-induced fatty liver is a reversible condition: evidence from a case of familial chylomicronemia syndrome","volume":"19","author":"Tramontano","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2025.10.073_bib0018","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/liv.15497","article-title":"Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia","volume":"43","author":"Larrey","year":"2023","journal-title":"Liver Int"},{"issue":"Suppl","key":"10.1016\/j.jacl.2025.10.073_bib0019","doi-asserted-by":"crossref","first-page":"119610","DOI":"10.1016\/j.atherosclerosis.2025.119610","article-title":"Real-world safety and effectiveness of lomitapide in homozygous familial hypercholesterolaemia over ten years: data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)","volume":"407","author":"Blom","year":"2025","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.jacl.2025.10.073_bib0020","doi-asserted-by":"crossref","first-page":"878","DOI":"10.5551\/jat.34777","article-title":"MTP gene variants and response to lomitapide in patients with homozygous familial hypercholesterolemia","volume":"23","author":"Kolovou","year":"2016","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.jacl.2025.10.073_bib0021","unstructured":"Agenzia Italiana Del Farmaco. Determina 1 marzo 2023. Inserimento del medicinale lomitapide (Lojuxta) nell'elenco istituito ai sensi della legge 23 dicembre 1996, n. 648, per il trattamento della sindrome da chilomicronemia familiare (iperlipoproteinemia di tipo I). (Determina n. 27277). (23A01444) (GU n.55 del 6-3-2023). https:\/\/www.gazzettaufficiale.it\/atto\/serie_generale\/caricaDettaglioAtto\/originario?atto.dataPubblicazioneGazzetta=2023-03-06&atto.codiceRedazionale=23A01444&elenco30giorni=false."},{"issue":"2","key":"10.1016\/j.jacl.2025.10.073_bib0022","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jacl.2012.11.006","article-title":"Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat","volume":"7","author":"Blackett","year":"2013","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2025.10.073_bib0023","first-page":"93","article-title":"The use of Orlistat in an adult with lipoprotein lipase deficiency: a case report","volume":"8","author":"Jarrett","year":"2021","journal-title":"AACE Clin Case Rep"},{"issue":"6","key":"10.1016\/j.jacl.2025.10.073_bib0024","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1210\/jc.2018-00369","article-title":"Orlistat therapy for children with type 1 hyperlipoproteinemia: a randomized clinical trial","volume":"103","author":"Patni","year":"2018","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425005021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425005021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:48:07Z","timestamp":1791373687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425005021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1933287425005021"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.10.073","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access program","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.10.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}